EdwardLewisLainMDMBA
Dermatology • Austin, TXAcne & Rosacea, Cosmetic Dermatology, Dermatologic Surgery, Pediatric Dermatology
Fellow of American Academy of Dermatology. Chief Medical Officer, Sanova Dermatology Executive Director, Austin Institute for Clinical Research
Dr. Lain is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5145 FM 620 N
Ste B-110
Austin, TX 78732Phone+1 512-266-0007Fax+1 512-266-0077
Summary
- Dr. Edward Lain is a dermatologist in Austin, TX. He received his medical degree from Baylor College of Medicine and has been in practice 15 years. He specializes in acne & rosacea, cosmetic dermatology, dermatologic surgery, and pediatric dermatology and is experienced in dermatologic surgery, cosmetic dermatology, pediatric dermatology, mohs micrographic surgery, and laser resurfacing/fractional laser resurfacing.
Education & Training
University of Arkansas for Medical Sciences (UAMS) College of MedicineResidency, Dermatology, 2003 - 2006- University of Arkansas for Medical Sciences (UAMS) College of MedicineInternship, Internal Medicine, 2002 - 2003
Rice University Jesse H Jones Graduate School of ManagementMBA, Healthcare Administration, 2000 - 2002
Baylor College of MedicineClass of 2002
Certifications & Licensure
TX State Medical License 2005 - 2026
AR State Medical License 2004 - 2007- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013
- Fellow (FAAD) American Academy of Dermatology
Clinical Trials
- VPD-737 for Treatment of Chronic Pruritus Start of enrollment: 2013 Oct 15
- A Treatment Regimen for Student Athletes With Mild to Moderate Acne Vulgaris Start of enrollment: 2014 Aug 01
- A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris Start of enrollment: 2015 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 23 citationsImpact of facial and truncal acne on quality of life: A multi-country population-based survey.Jerry Tan, Stefan Beissert, Fran Cook-Bolden, Rajeev Chavda, Julie C Harper
JAAD International. 2021-04-27 - 17 citationsEfficacy and Safety of a Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: A Randomized Phase II Study...Linda Stein Gold, Hilary Baldwin, Leon H Kircik, Jonathan S. Weiss, David M. Pariser
American Journal of Clinical Dermatology. 2021-10-21 - 3 citationsTriple-combination clindamycin phosphate 1.2%/benzoyl peroxide 3.1%/adapalene 0.15% gel for moderate-to-severe acne in children and adolescents: Randomized phase 2 study.Lawrence F Eichenfield, Linda Stein Gold, Leon H Kircik, William P Werschler, Kenneth Beer
Pediatric Dermatology. 2023-03-22
Press Mentions
Athenex Announces Positive Topline Results from Two Phase III Studies of KX2-391 Ointment 1% Featured in Late Breaker Program at the 2019 American Academy of Dermatology Annual MeetingMarch 4th, 2019
Galderma Announces Positive Results from the “CoMMPlete” Regimen Study Including Epiduo® Gel in the Management of Acne in Adolescent Student AthletesMay 24th, 2016
Professional Memberships
- Fellow
- Member
- Member
- Fellow
External Links
- Dr Ted Lain Dermatologyhttp://www.atxderm.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
